Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Silo Pharma (SILO) Enterprise Value (2019 - 2025)

Silo Pharma's Enterprise Value history spans 7 years, with the latest figure at -$5.9 million for Q3 2025.

  • For Q3 2025, Enterprise Value rose 26.81% year-over-year to -$5.9 million; the TTM value through Sep 2025 reached -$5.9 million, up 26.81%, while the annual FY2024 figure was -$7.1 million, 7.63% up from the prior year.
  • Enterprise Value for Q3 2025 was -$5.9 million at Silo Pharma, up from -$6.3 million in the prior quarter.
  • Across five years, Enterprise Value topped out at -$4.2 million in Q2 2021 and bottomed at -$12.3 million in Q3 2022.
  • The 5-year median for Enterprise Value is -$8.0 million (2024), against an average of -$8.2 million.
  • The largest annual shift saw Enterprise Value tumbled 50611.35% in 2021 before it soared 36.85% in 2024.
  • A 5-year view of Enterprise Value shows it stood at -$10.3 million in 2021, then decreased by 10.85% to -$11.4 million in 2022, then skyrocketed by 32.58% to -$7.7 million in 2023, then increased by 7.63% to -$7.1 million in 2024, then rose by 17.15% to -$5.9 million in 2025.
  • Per Business Quant, the three most recent readings for SILO's Enterprise Value are -$5.9 million (Q3 2025), -$6.3 million (Q2 2025), and -$5.5 million (Q1 2025).